vTv Therapeutics Inc. logo

vTv Therapeutics Inc.

NASDAQ:VTVT

Overview | Financials
Company Name vTv Therapeutics Inc.
Symbol VTVT
Currency USD
Price 13.87
Market Cap 36,232,046
Dividend Yield 0%
52-week-range 7.38 - 30.99
Industry Biotechnology
Sector Healthcare
CEO Mr. Paul J. Sekhri M.Sc., MSc
Website https://www.vtvtherapeutics.com

An error occurred while fetching data.

About vTv Therapeutics Inc.

vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor

Related Stocks

ARCA biopharma, Inc. logo

ARCA biopharma, Inc.

ABIO

28.8 USD

T2 Biosystems, Inc. logo

T2 Biosystems, Inc.

TTOO

0.345 USD

Acer Therapeutics Inc. logo

Acer Therapeutics Inc.

ACER

0.66 USD

Immix Biopharma, Inc. logo

Immix Biopharma, Inc.

IMMX

2.18 USD

Avalo Therapeutics, Inc. logo

Avalo Therapeutics, Inc.

AVTX

8.81 USD

Financials

Numbers are in millions USD

Numbers are in millions USD